These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 21404630

  • 21. Psilocybin in pharmacotherapy of obsessive-compulsive disorder.
    Owe-Larsson M, Kamińska K, Buchalska B, Mirowska-Guzel D, Cudnoch-Jędrzejewska A.
    Pharmacol Rep; 2024 Oct; 76(5):911-925. PubMed ID: 39088105
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B, Nestadt G, Allen A, Hollander E.
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacotherapy for obsessive-compulsive disorder.
    Dougherty DD, Rauch SL, Jenike MA.
    J Clin Psychol; 2004 Nov; 60(11):1195-202. PubMed ID: 15389617
    [Abstract] [Full Text] [Related]

  • 29. Obsessive compulsive disorder: serotonin and beyond.
    Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D.
    World J Biol Psychiatry; 2000 Apr; 1(2):92-100. PubMed ID: 12607204
    [Abstract] [Full Text] [Related]

  • 30. Structural and functional brain imaging after treatment with selective-serotonin reuptake-inhibitors in obsessive-compulsive disorder: A mini review.
    Bracco L, Dusi N, Moltrasio C, Brambilla P, Delvecchio G.
    J Affect Disord; 2024 Jan 15; 345():141-148. PubMed ID: 37820957
    [Abstract] [Full Text] [Related]

  • 31. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    J Clin Psychiatry; 1992 Apr 15; 53 Suppl():29-37. PubMed ID: 1532962
    [Abstract] [Full Text] [Related]

  • 32. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A, Hollander E.
    Psychiatr Serv; 2003 Aug 15; 54(8):1111-8. PubMed ID: 12883138
    [Abstract] [Full Text] [Related]

  • 33. Obsessive-compulsive disorder.
    Bokor G, Anderson PD.
    J Pharm Pract; 2014 Apr 15; 27(2):116-30. PubMed ID: 24576790
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
    Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V.
    J Affect Disord; 2010 Feb 15; 121(1-2):175-9. PubMed ID: 19577308
    [Abstract] [Full Text] [Related]

  • 36. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R.
    JAMA Psychiatry; 2013 Nov 15; 70(11):1190-9. PubMed ID: 24026523
    [Abstract] [Full Text] [Related]

  • 37. Beyond depression: citalopram for obsessive-compulsive disorder.
    Pato MT.
    Int Clin Psychopharmacol; 1999 May 15; 14 Suppl 2():S19-26. PubMed ID: 10471169
    [Abstract] [Full Text] [Related]

  • 38. Pharmacotherapy for obsessive-compulsive disorder.
    Greist JH, Jefferson JW.
    Br J Psychiatry Suppl; 1998 May 15; (35):64-70. PubMed ID: 9829028
    [Abstract] [Full Text] [Related]

  • 39. Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study.
    Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E.
    CNS Drugs; 2009 Dec 15; 23(12):1047-55. PubMed ID: 19958042
    [Abstract] [Full Text] [Related]

  • 40. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
    Poppe C, Müller ST, Greil W, Walder A, Grohmann R, Stübner S.
    J Affect Disord; 2016 Aug 15; 200():89-96. PubMed ID: 27130958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.